Hypopotassemia ICD-10-CM Alphabetical Index. The ICD-10-CM Alphabetical Index is designed to allow medical coders to look up various medical terms and connect them with the appropriate ICD codes. There are 0 terms under the parent term 'Hypopotassemia' in the ICD-10-CM Alphabetical Index .
642 Inborn and other disorders of metabolism. Diabetes, diabetic (mellitus) (sugar) E11.9 ICD-10-CM Diagnosis Code E11.9 ICD-10-CM Diagnosis Code E88.9 ICD-10-CM Diagnosis Code E83.30 ICD-10-CM Diagnosis Code E88.9 Hyperphosphatemia E83.39 Hypophosphatemia, hypophosphatasia (acquired) (congenital)...
Potassium chloride 10 mEq (750 mg) is not a controlled substance under the Controlled Substances Act (CSA). Get help with Imprint Code FAQs.
Hypokalemia. The 2019 edition of ICD-10-CM E87.6 became effective on October 1, 2018. This is the American ICD-10-CM version of E87.6 - other international versions of ICD-10 E87.6 may differ.
Convert to ICD-10-CM: 276.8 converts directly to: 2015/16 ICD-10-CM E87. 6 Hypokalemia.
001180: Potassium | Labcorp.
ICD-10-CM Code for Hyperkalemia E87. 5.
ICD-10 | Hypokalemia (E87. 6)
A potassium blood test is often included in a series of routine blood tests called an electrolyte panel. The test may also be used to monitor or diagnose conditions related to abnormal potassium levels. These conditions include kidney disease, high blood pressure, and heart disease.
ICD-Code I10 is a billable ICD-10 code used for healthcare diagnosis reimbursement of Essential (Primary) Hypertension.
ICD-10 Code for Person consulting for explanation of examination or test findings- Z71. 2- Codify by AAPC.
ICD-10 code R79. 9 for Abnormal finding of blood chemistry, unspecified is a medical classification as listed by WHO under the range - Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified .
ICD-10 Code for Encounter for issue of repeat prescription- Z76. 0- Codify by AAPC.
ICD-10 code I50. 2 for Systolic (congestive) heart failure is a medical classification as listed by WHO under the range - Diseases of the circulatory system .
Essential (primary) hypertension: I10 That code is I10, Essential (primary) hypertension. As in ICD-9, this code includes “high blood pressure” but does not include elevated blood pressure without a diagnosis of hypertension (that would be ICD-10 code R03. 0).
Potassium chloride extended-release capsules are indicated for the treatment and prophylaxis of hypokalemia in adults and children with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insufficient.
The normal potassium ion content of human milk is about 13 mEq per liter. Since oral potassium becomes part of the body potassium pool, as long as body potassium is not excessive, the contribution of potassium chloride supplementation should have little or no effect on the level in human milk.
Pediatric patients aged birth to 16 years old: Dosage must be adjusted to the individual needs of each patient. Do not exceed as a single dose 1 mEq/kg or 20 mEq , whichever is lower.
Dosage must be adjusted to the individual needs of each patient. Dosages greater than 40 mEq per day should be divided such that no more than 40 mEq is given in a single dose.
Potassium ions participate in a number of essential physiological processes, including the maintenance of intracellular tonicity; the transmission of nerve impulses; the contraction of cardiac, skeletal, and smooth muscle; and the maintenance of normal renal function.
Patients with renal impairment have reduced urinary excretion of potassium and are at substantially increased risk of hyperkalemia. Patients with impaired renal function, particularly if the patient is on RAAS inhibitors or nonsteroidal anti-inflammatory drugs, should usually be started at the low end of the dosing range because of the potential for development of hyperkalemia [see Drug Interactions ( 7.2, 7.3 ] . The serum potassium level should be monitored frequently. Renal function should be assessed periodically.
There are no human data related to use of potassium chloride extended-release capsules during pregnancy and animal reproductive studies have not been conducted. Potassium supplementation that does not lead to hyperkalemia is not expected to cause fetal harm.
Generic name: Potassium extended-release - oral . Pronunciation. (poe-TAS-ee-um) Brand name (s) Micro-K. Uses. This medication is a mineral supplement used to treat or prevent low amounts of potassium in the blood. A normal level of potassium in the blood is important.
Tell your doctor if your condition does not improve or if you have symptoms of low potassium in the blood (such as irregular heartbeat, muscle weakness/cramps). Upset stomach, nausea, vomiting, gas, or diarrhea may occur. If any of these effects persist or worsen, tell your doctor or pharmacist promptly.
A normal level of potassium in the blood is important. Potassium helps your cells, kidneys, heart, muscles, and nerves work properly. Most people get enough potassium by eating a well-balanced diet.
Foods high in potassium include bananas, oranges, cantaloupe, raisins, dates, prunes, avocados, apricots, beans, broccoli, spinach, potatoes, lentils, chicken, turkey, beef, and yogurt. Consult your doctor or dietician for recommended foods. Missed dose. If you miss a dose, take it as soon as you remember.
kidney problems. high levels of potassium in the blood. Due to rare reports of stomach/intestinal ulcers and bleeding with sustained-release potassium products, taking a liquid form of potassium is preferred. Tell your doctor or pharmacist if you have throat/stomach/intestinal problems such as blockage, narrowing, or ulcers.
Potassium Chloride Extended-release Tablets, USP is indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insufficient.
If serum potassium concentration is less than 2.5 mEq/L, use intravenous potassium instead of oral supplementation.
Potassium chloride is contraindicated in patients on triamterene and amiloride.
Solid oral dosage forms of potassium chloride can produce ulcerative and/or stenotic lesions of the gastrointestinal tract, particularly if the drug maintains contact with the gastrointestinal mucosa for prolonged periods.
Use with triamterene or amiloride can produce severe hyperkalemia. Concomitant use is contraindicated [see Contraindications (4)] .
There are no human data related to use of Potassium Chloride Extended-release Tablets, USP during pregnancy, and animal reproduction studies have not been conducted. Potassium supplementation that does not lead to hyperkalemia is not expected to cause fetal harm.
The administration of oral potassium salts to persons with normal excretory mechanisms for potassium rarely causes serious hyperkalemia. However, if excretory mechanisms are impaired, potentially fatal hyperkalemia can result [ see CONTRAINDICATIONS and WARNINGS] .